{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T03:29:55Z","timestamp":1774841395915,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"8","content-domain":{"domain":["ejcancer.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.ejca.2014.01.023","type":"journal-article","created":{"date-parts":[[2014,2,19]],"date-time":"2014-02-19T09:15:22Z","timestamp":1392801322000},"page":"1555-1565","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Novel 1p tumour suppressor Dnmt1-associated protein 1 regulates MYCN\/ataxia telangiectasia mutated\/p53 pathway"],"prefix":"10.1016","volume":"50","author":[{"given":"Yohko","family":"Yamaguchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisanori","family":"Takenobu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miki","family":"Ohira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuko","family":"Nakazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayaka","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhiro","family":"Akita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Shimozato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Iwama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Nakagawara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehiko","family":"Kamijo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2014.01.023_b0005","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrc1014","article-title":"Neuroblastoma: biological insights into a clinical enigma","volume":"3","author":"Brodeur","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ejca.2014.01.023_b0010","first-page":"1357","article-title":"Deletion mapping defines different regions in 1p34.2-pter that may harbor genetic information related to human colorectal cancer","volume":"11","author":"Praml","year":"1995","journal-title":"Oncogene"},{"key":"10.1016\/j.ejca.2014.01.023_b0015","first-page":"1752","article-title":"Detection and cloning of a common region of loss of heterozygosity at chromosome 1p in breast cancer","volume":"55","author":"Nagai","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2014.01.023_b0020","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1200\/JCO.2000.18.3.636","article-title":"Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas","volume":"18","author":"Smith","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2014.01.023_b0025","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1002\/cncr.23778","article-title":"Genetic aberrations of gastrointestinal stromal tumors","volume":"113","author":"Yang","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2014.01.023_b0030","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1200\/JCO.2000.18.9.1888","article-title":"Loss of heterozygosity at 1p36 independently predicts for disease progression but not decreased overall survival probability in neuroblastoma patients: a Children\u2019s Cancer Group study","volume":"18","author":"Maris","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2014.01.023_b0035","first-page":"5681","article-title":"Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms","volume":"55","author":"Martinsson","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2014.01.023_b0040","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1038\/sj.onc.1208306","article-title":"Definition and characterization of a region of 1p36.3 consistently deleted in neuroblastoma","volume":"24","author":"White","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.ejca.2014.01.023_b0045","first-page":"6481","article-title":"No evidence for the presence of an imprinted neuroblastoma suppressor gene within chromosome sub-band 1p36.3","volume":"62","author":"Hogarty","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2014.01.023_b0050","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/77023","article-title":"DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci","volume":"25","author":"Rountree","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.ejca.2014.01.023_b0055","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1111\/j.1365-2443.2009.01352.x","article-title":"Dmap1 plays an essential role in the maintenance of genome integrity through the DNA repair process","volume":"14","author":"Negishi","year":"2009","journal-title":"Genes Cells"},{"key":"10.1016\/j.ejca.2014.01.023_b0060","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/onc.2012.597","article-title":"DMAP1 is an essential regulator of ATM activity and function","volume":"33","author":"Penicud","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.ejca.2014.01.023_b0065","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/onc.2010.383","article-title":"CD133 suppresses neuroblastoma cell differentiation via signal pathway modification","volume":"30","author":"Takenobu","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.ejca.2014.01.023_b0070","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrm2514","article-title":"Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer","volume":"9","author":"Lavin","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.ejca.2014.01.023_b0075","series-title":"Cancer chemotherapy and biotherapy: principles and practice","first-page":"356","article-title":"Topoisomerase II inhibitors: anthracyclines","author":"James","year":"2011"},{"key":"10.1016\/j.ejca.2014.01.023_b0080","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1016\/j.ejca.2010.05.026","article-title":"HDM2 impairs Noxa transcription and affects apoptotic cell death in a p53\/p73-dependent manner in neuroblastoma","volume":"46","author":"Shi","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2014.01.023_b0085","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1073\/pnas.0907763107","article-title":"ATM is down-regulated by N-Myc-regulated microRNA-421","volume":"107","author":"Hu","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ejca.2014.01.023_b0090","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1038\/sj.onc.1202435","article-title":"MycN sensitizes neuroblastoma cells for drug-induced apoptosis","volume":"18","author":"Fulda","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.ejca.2014.01.023_b0095","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0959-437X(05)80339-9","article-title":"The role of c-myc in cell growth","volume":"3","author":"Evan","year":"1993","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.ejca.2014.01.023_b0100","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/305245a0","article-title":"Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour","volume":"305","author":"Schwab","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.ejca.2014.01.023_b0105","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1038\/onc.2009.512","article-title":"Myc proteins as therapeutic targets","volume":"29","author":"Gustafson","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.ejca.2014.01.023_b0110","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1747-1028-7-6","article-title":"Two sides of the Myc-induced DNA damage response: from tumor suppression to tumor maintenance","volume":"7","author":"Campaner","year":"2012","journal-title":"Cell Div"},{"key":"10.1016\/j.ejca.2014.01.023_b0115","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1016\/j.febslet.2010.05.031","article-title":"Multiple roles of ATM in monitoring and maintaining DNA integrity","volume":"584","author":"Derheimer","year":"2010","journal-title":"FEBS Lett"},{"key":"10.1016\/j.ejca.2014.01.023_b0120","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1158\/1541-7786.MCR-10-0227","article-title":"MYCN sensitizes human neuroblastoma to apoptosis by HIPK2 activation through a DNA damage response","volume":"9","author":"Petroni","year":"2011","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.ejca.2014.01.023_b0125","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1056\/NEJM198705213162101","article-title":"Breast and other cancers in families with ataxia-telangiectasia","volume":"316","author":"Swift","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2014.01.023_b0130","first-page":"5269","article-title":"Absence of p53 gene mutations in primary neuroblastomas","volume":"53","author":"Vogan","year":"1993","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2014.01.023_b0135","first-page":"8","article-title":"Evidence for the development of p53 mutations after cytotoxic therapy in a neuroblastoma cell line","volume":"61","author":"Tweddle","year":"2001","journal-title":"Cancer Res"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804914000963?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804914000963?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T15:31:04Z","timestamp":1565191864000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804914000963"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0959804914000963"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2014.01.023","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel 1p tumour suppressor Dnmt1-associated protein 1 regulates MYCN\/ataxia telangiectasia mutated\/p53 pathway","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2014.01.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}